Wilbert Zwart
Wilbert Zwart
Professor Functional Genomics in Oncology, Groupleader, The Netherlands Cancer Institute
Verified email at nki.nl - Homepage
Title
Cited by
Cited by
Year
Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioning
N Rocha, C Kuijl, R Van Der Kant, L Janssen, D Houben, H Janssen, ...
Journal of Cell Biology 185 (7), 1209-1225, 2009
5232009
Activation of endosomal dynein motors by stepwise assembly of Rab7–RILP–p150Glued, ORP1L, and the receptor βlll spectrin
M Johansson, N Rocha, W Zwart, I Jordens, L Janssen, C Kuijl, ...
The Journal of cell biology 176 (4), 459-471, 2007
4562007
A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility
M Kedde, M Van Kouwenhove, W Zwart, JAFO Vrielink, R Elkon, R Agami
Nature cell biology 12 (10), 1014-1020, 2010
3882010
Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9
G Korkmaz, R Lopes, AP Ugalde, E Nevedomskaya, R Han, K Myacheva, ...
Nature biotechnology 34 (2), 192-198, 2016
2992016
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
2842013
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
B Pang, X Qiao, L Janssen, A Velds, T Groothuis, R Kerkhoven, ...
Nature communications 4 (1), 1-13, 2013
2752013
TRPM7 is required for breast tumor cell metastasis
J Middelbeek, AJ Kuipers, L Henneman, D Visser, I Eidhof, ...
Cancer research 72 (16), 4250-4261, 2012
1762012
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
CJ Desmet, T Gallenne, A Prieur, F Reyal, NL Visser, BS Wittner, MA Smit, ...
Proceedings of the National Academy of Sciences 110 (13), 5139-5144, 2013
1482013
Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape
W Zwart, A Griekspoor, C Kuijl, M Marsman, J van Rheenen, H Janssen, ...
Immunity 22 (2), 221-233, 2005
1422005
Phosphatidylinositol 4-kinaseβ is critical for functional association of rab11 with the Golgi complex
P de Graaf, WT Zwart, RAJ van Dijken, M Deneka, TKF Schulz, N Geijsen, ...
Molecular biology of the cell 15 (4), 2038-2047, 2004
1392004
PKA‐induced resistance to tamoxifen is associated with an altered orientation of ERα towards co‐activator SRC‐1
W Zwart, A Griekspoor, V Berno, K Lakeman, K Jalink, M Mancini, ...
The EMBO journal 26 (15), 3534-3544, 2007
1272007
Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer
W Zwart, V Theodorou, M Kok, S Canisius, S Linn, JS Carroll
The EMBO journal 30 (23), 4764-4776, 2011
1162011
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ...
Breast cancer research and treatment 133 (1), 37-47, 2012
1082012
Visualizing the action of steroid hormone receptors in living cells
A Griekspoor, W Zwart, J Neefjes, R Michalides
Nuclear receptor signaling 5 (1), nrs. 05003, 2007
1052007
The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen
W Zwart, R de Leeuw, M Rondaij, J Neefjes, MA Mancini, R Michalides
Journal of cell science 123 (8), 1253-1261, 2010
952010
Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface
IJ De Vries-van Leeuwen, D da Costa Pereira, KD Flach, SR Piersma, ...
Proceedings of the National Academy of Sciences 110 (22), 8894-8899, 2013
932013
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ...
Nature 572 (7770), 538-542, 2019
812019
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
K Beelen, W Zwart, SC Linn
Nature reviews Clinical oncology 9 (9), 529-541, 2012
802012
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer
MPHM Jansen, T Knijnenburg, EA Reijm, I Simon, R Kerkhoven, M Droog, ...
Cancer research 73 (22), 6632-6641, 2013
782013
Tamoxifen resistance: from bench to bedside
M Droog, K Beelen, S Linn, W Zwart
European journal of pharmacology 717 (1-3), 47-57, 2013
782013
The system can't perform the operation now. Try again later.
Articles 1–20